 Provider News IndianaNovember 2024 Provider NewsletterThe Department of Health & Human Services (HHS) requires health plans to report whether or not our in-network providers offer telehealth services. If you provide telehealth services, please tell us by submitting your information to us through Availity.com. Updating your telehealth status will not affect your participation with us. We will add a telehealth indicator to your online provider directory profile, allowing our members to know you offer telehealth services. If you have questions about submitting your information, please see the instructions below. If your organization is not currently registered with Availity, you will need to create an account. The person(s) designated as your administrator(s) should go to Availity.com and select Get Started in the upper right corner of the webpage. You may also navigate directly to Availity’s registration website by selecting here. Begin your application here. To update your application: - Log in to Availity Essentials.
- Select My Providers.
- Select Provider Data Management.
Please update your telehealth information at the service location. Anthem Blue Cross and Blue Shield is the trade name of Anthem Insurance Companies, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-069888-24-CPN69222 Administrative | Hoosier Healthwise, Healthy Indiana Plan, Hoosier Care Connect, and IN PathWays for Aging | November 1, 2024 Evaluation and management services correct codingAnthem continues to be dedicated to delivering access to quality care for our members, providing higher value to our customers and helping improve the health of our communities. In an ongoing effort to promote accurate claims processing and payment, Anthem is taking additional steps to assess selected claims for evaluation and management (E/M) services submitted by professional providers. Beginning on February 1, 2025, we will be using an analytic solution to facilitate a review of whether coding on these claims is aligned with national industry coding standards. Providers should report E/M services in accordance with the American Medical Association (AMA) CPT® manual and CMS' guidelines for billing E/M service codes, Documentation Guidelines for Evaluation and Management. The appropriate level of service is based primarily on the documented medical history, examination, and medical decision-making. Counseling, coordination of care, the nature of the presenting problem, and face-to-face time are considered contributing factors. The coded service should reflect and not exceed that needed to manage the member’s condition(s). Claims will be selected from providers who are identified as coding at a higher E/M level compared to their peers with similar risk-adjusted members. Prior to payment, Anthem will review the selected E/M claims to determine, in accordance with correct coding requirements and/or reimbursement policy as applicable, whether the E/M code level submitted is higher than the E/M code level supported on the claim. If the E/M code level submitted is higher than the E/M code level supported on the claim, Anthem reserves the right to: - Deny the claim and request resubmission of the claim with the appropriate E/M level.
- Pend the claim and request documentation supporting the E/M level billed.
- Adjust reimbursement to reflect the lower E/M level supported by the claim.
The maximum level of service for E/M codes will be based on the complexity of the medical decision-making and reimbursed at the supported E/M code level and fee schedule rate. What is the impact of this change?This initiative will not impact every level four or five E/M claim. Providers whose coding patterns improve and are no longer identified as an outlier are eligible to be removed from the program. Providers who believe their medical record documentation supports reimbursement for the originally submitted level for the E/M service will be able to follow the dispute resolution process (including submission of such documentation with the dispute). Anthem Blue Cross and Blue Shield is the trade name of Anthem Insurance Companies, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.
Providers who are contracted with Anthem Blue Cross and Blue Shield to serve Hoosier Healthwise, Healthy Indiana Plan, Hoosier Care Connect, and IN PathWays for Aging through an accountable care organization (ACO), participating medical group (PMG) or Independent Physician Association (IPA) are to follow guidelines and practices of the group. This includes but is not limited to authorization, covered benefits and services, and claims submittal. If you have questions, please contact your group administrator or your Anthem network representative. INBCBS-CD-067737-24 Beginning with claims processing on or after December 1, 2024, we will update our outpatient facility claims editing process to deny claim lines when an add-on code is reported without a primary procedure code. An add-on code is a specific type designated by the HCPCS or CPT®. These codes describe additional procedures or services performed with a primary procedure. According to CPT guidelines, add-on codes must be reported with a primary procedure code. If you believe you have received a claim denial in error, please follow our claim dispute process. With your help, we can continually build towards a future of shared success. Anthem Blue Cross and Blue Shield is the trade name of Anthem Insurance Companies, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-070181-24-CPN69226 In July, we announced an enhancement to the 277CA to notify you of submission errors discovered during claims processing.
As of November 1, 2024, the 277CA will include additional corrective action types for your review. As communicated in July, these errors will still be sent through physical mailing.
With these added error types, there is no reduction to the services we already provide.
Through our efforts, we are committed to reducing administrative burden, improving communication, and ensuring timely payments because we value you, our care provider partners.
Anthem Blue Cross and Blue Shield is the trade name of Anthem Insurance Companies, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-069544-24-CPN69313 Find Care, the doctor finder and transparency tool in the Anthem online directory, provides Anthem members with the ability to search for in-network providers using the secure member website. This tool currently offers multiple sorting options such as sorting providers based on distance, alphabetical order, and provider name. In our November 2022 newsletter, we provided an update regarding Personalized Match, an additional Find Care sorting option for Commercial members. We informed you that this provider sorting option was based on provider efficiency and quality outcomes described in a methodology document linked in the newsletter article, in addition to member search radius. We want to inform you that, beginning in December 2024 or later, we will be enhancing Personalized Match. This will expand upon the existing program. Newer components of the provider personalization metrics will contain up to 10 times as many features as compared to existing metrics such as gaps in care and additional types of service cost and utilization. Personalized Match will continue to display providers with the highest overall ranking within the member’s search radius, first. Members will continue to have the ability to sort based on distance, alphabetical order, and provider name. Helpful resources on AvailityYou may review a copy of the Personalized Match methodology that has been posted on Availity, our secure web-based provider tool, using the following navigation: - Go to Availity > Payer Spaces > Health Plan > Education & Reference Center > Administrative Support > Personalized Match Methodology.pdf.
If you have general questions regarding these upcoming changes, please submit an inquiry via the web at Availity.com. If you would like information about your quality or efficiency scoring used as part of this sorting option or if you would like to request reconsideration of those scores, you may do so by submitting an inquiry to Availity.com. Anthem will continue to focus and expand our consumer tools and content to assist members in making more informed and personalized healthcare decisions. Anthem Blue Cross and Blue Shield is the trade name of Anthem Insurance Companies, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-061391-24, MULTI-BCBS-CM-070287-24 Anthem has a continued mission to leverage digital technology to provide enhanced services for both members and care providers. We encourage the support of care providers in accepting digital ID cards instead of a physical member ID card. As members increasingly use digital ID cards, care providers may need to implement changes in their processes to accept this format. Due to recent enhancements, care providers can bypass the request for cards by accessing Availity.com. If a copy of a physical member identification card is needed, a member can email, fax, or access card details saved in their digital wallet. As a reminder, care providers can also access eligibility and benefit information without the health care identification (HCID). This makes both check-ins and submitting claims easier and faster. Anthem is dedicated to providing digital solutions that transform both care provider and payer interactions. Thank you in advance for your continued partnership and support in empowering our members to use their digital ID cards. With your help, we can continually build towards a future of shared success. Anthem Blue Cross and Blue Shield is the trade name of Anthem Insurance Companies, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-069066-24, MULTI-BCBS-CM-077976-25 We are in the process of shutting down specific authorization fax channels. This is to notify you that the fax numbers below will be decommissioned on November 15, 2024.
Look for additional notifications as other authorization fax lines are retired.
Availity Essentials is the preferred method for authorization intakes. If you cannot use Availity Essentials, call our contact center at 833-545-9102, and we will work with you to determine the best submission method.
Available resources
Registering and accessing Availity Essentials is easy. If your organization is not registered for Availity Essentials, see Register and get started with Availity Essentials (Availity.com).
If you are not already familiar with Availity Essentials, training is available. Register for training today. Under Help and Learning, select Get Trained and learn about the simple workflow for submitting digital authorizations.
These fax numbers will be turned off on November 15, 2024.
800-773-7797
|
800-266-3504
|
866-959-1393
|
877-254-4971
|
866-959-1395
|
404-467-2600
|
404-842-8390
|
404-848-2448
|
804-354-2578
|
804-354-3307
|
804-354-3882
|
804-678-0650
|
|
|
|
Anthem Blue Cross and Blue Shield is the trade name of Anthem Insurance Companies, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-070105-24 We are excited to announce the release of an Applied Behavior Analysis (ABA) Provider Resource Guide designed to assist with proper billing and documentation practices. This essential guide simplifies the complexities of ABA coding and requirements, ensuring that you can navigate these processes with ease. Refer to attached ABA Provider Resource Guide. Anthem Blue Cross and Blue Shield is the trade name of Anthem Insurance Companies, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-072382-24-CPN72379 ATTACHMENTS (available on web): ABA Provider Resource Guide - Anthem Blue Cross Blue Shield (pdf - 0.39mb) Behavioral Health | Hoosier Healthwise, Healthy Indiana Plan, Hoosier Care Connect, and IN PathWays for Aging | October 9, 2024 Drug testing covered in ASAM level 3.1 and 3.5 per diem bundlesAnthem embraces opportunities to foster collaboration efforts with care providers to help ensure proper coding and payment of claims. A recent review showed that drug testing claims are being submitted for members in treatment at residential treatment centers (RTCs) for substance use disorders (SUDs) for American Society of Addiction Medicine (ASAM) levels 3.1 and 3.5. The Indiana Health Coverage Program (IHCP) Provider Reference Module for Behavioral Health Services states that drug testing is included in the bundle of services covered by the per diem payment for ASAM levels 3.1 and 3.5. Table 3 ─ low-intensity residential treatment (ASAM level 3.1) billing guidanceServices included in per diem | Procedure code | Description | - Individual therapy
- Group therapy
- Medication training and support
- Case management
- Drug testing
- Peer recovery supports
| H2034 | Alcohol and/or drug abuse half-way house service, per diem |
Table 4 ─ high-intensity residential treatment (ASAM level 3.5*) billing guidanceServices included in per diem | Procedure code | Description | - Individual therapy
- Group therapy
- Medication training and support
- Case management
- Drug testing
- Peer recovery supports
- Skills training and development
| H0010 | Alcohol and/or drug services; acute detoxification (residential addiction program inpatient) | ASAM 3.5 is considered medium-intensity residential treatment for adolescents. |
Coverage for drug testing with service codes 80305, 80306, 80307, G0480, G0481, and G0482 are included in the per diem payment for RTC 3.5 level of care (procedure code H0010) and RTC 3.1 level of care (procedure code H2034) when the member is in active treatment in that level of care. Anthem will soon ensure that the billing guidance related to drug testing during residential treatment set forth in the IHCP Provider Reference Module is being followed. Claims submitted that do not adhere to this guidance will be denied. We are grateful for your care of our members and look forward to continued collaboration. Anthem Blue Cross and Blue Shield is the trade name of Anthem Insurance Companies, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.
Providers who are contracted with Anthem Blue Cross and Blue Shield to serve Hoosier Healthwise, Healthy Indiana Plan, Hoosier Care Connect, and IN PathWays for Aging through an accountable care organization (ACO), participating medical group (PMG) or Independent Physician Association (IPA) are to follow guidelines and practices of the group. This includes but is not limited to authorization, covered benefits and services, and claims submittal. If you have questions, please contact your group administrator or your Anthem network representative. INBCBS-CD-065141-24 Behavioral Health | Hoosier Healthwise, Healthy Indiana Plan, Hoosier Care Connect, and IN PathWays for Aging | October 4, 2024 Claims analysis of claims billed using the HL modifierAnthem embraces opportunities to foster collaboration efforts with providers to help ensure proper coding and payment of claims. To this end, we regularly review the Indiana Health Coverage Programs Provider Reference Modules to ensure we are processing claims in a way that is consistent with state guidance. This letter is sent as a reminder that, per the Indiana Health Coverage Programs (IHCP) Provider References Module for Behavioral Health Services (p. 6) and in accordance with BT201859: - The IHCP allows reimbursement for services provided by interns in the community mental health center (CMHC) setting. The provider billing for these services must be enrolled with the IHCP as a CMHC (provider type 11, specialty 111). CMHCs owned by or affiliated with a hospital, however, are an exception to this allowance. CMHCs associated with hospitals may not bill separately for intern services because reimbursement for intern services is included in the hospital’s medical education add-on to inpatient claims.
- To qualify for reimbursement, the intern must be a graduate or postgraduate student currently enrolled in an accredited college or university program in one of the following fields of study:
- Medical (including physician assistant)
- Nursing
- Behavioral health (including mental health and addiction treatment)
Further, the student must be approved by the college or university to work as an intern or practicum student at a CMHC. For reimbursement, the intern must be supervised by an IHCP-enrolled practitioner who is employed by or under contract with the billing CMHC. The services rendered by the intern must be within the supervising practitioner's scope of practice. The following billing guidance applies to services rendered by interns: - Services must be billed on a professional claim (CMS-1500 claim form or electronic equivalent).
- The supervising practitioner should be listed as the rendering provider on the claim.
- The modifier HL (intern) should be used to indicate that the service was performed by an intern.
- Reimbursement for intern services is at 50 percent of the professional fee schedule amount published on the Professional Fee Schedule, accessible from the fee schedules page at in.gov/medicaid/providers.
We are grateful for your care of our members and look forward to continued collaboration. Anthem Blue Cross and Blue Shield is the trade name of Anthem Insurance Companies, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.
Providers who are contracted with Anthem Blue Cross and Blue Shield to serve Hoosier Healthwise, Healthy Indiana Plan, Hoosier Care Connect, and IN PathWays for Aging through an accountable care organization (ACO), participating medical group (PMG) or Independent Physician Association (IPA) are to follow guidelines and practices of the group. This includes but is not limited to authorization, covered benefits and services, and claims submittal. If you have questions, please contact your group administrator or your Anthem network representative. INBCBS-CD-067045-24 As a contracted provider for a special needs plan (SNP) from Anthem, you are required to participate in an annual Model of Care training for providers, per CMS regulations. This training includes a detailed overview of Anthem special needs plans and program information, highlighting cost sharing, data sharing, participation in the Interdisciplinary Care team (ICT), where to access the member’s health risk assessment results, plan of care, and benefit coordination. Please remember this training is specific to our plans and delivery of care for members, ensuring their specific care needs are met. Your participation is critical for improved quality and health outcomes. Training for the SNP product is self-paced and available at Availity.com. The training must be completed by December 31, 2024. How to access the Custom Learning Center:- Log in to the Availity website at Availity.com.
- At the top of the Availity website, select Payer Spaces and select the appropriate payer.
- On the Payer Spaces landing page, select Access Your Custom Learning Center from Applications.
- In the Custom Learning Center, select Required Training.
- Select Special Needs Plan and Model of Care Overview.
- Select Enroll.
- Select Start.
- Once the course is completed, select Begin Attestation and complete.
Not registered for Availity Essentials?Have your organization’s designated administrator register your organization for the Availity website: - Visit Availity.com to register.
- Select Register.
- Select your organization type.
- In the Registration wizard, follow the prompts to complete the registration for your organization.
Refer to these PDF documents for complete registration instructions. Anthem Blue Cross and Blue Shield is the trade name of Anthem Insurance Companies, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CR-070560-24-CPN70218 In the July 2024 edition of Provider News, we announced the transition to the following Carelon Medical Benefits Management guidelines: Site of Care for Advanced Imaging, Rehabilitative Site of Care, and Surgical Site of Care, effective September 1, 2024. To clarify, existing prior authorization requirements have not changed, and this does not equate to the presence of a site of care review requirement. In the event a site of care review requirement for these services will be implemented, a separate notice will be distributed before the addition of any such requirements. You may access and download a copy of the current and upcoming guidelines here. Site of Care Guidelines: - Site of Care for Advanced Imaging
- Rehabilitative Site of Care
- Surgical Site of Care
Please share this notice with other members of your practice and office staff. Anthem Blue Cross and Blue Shield is the trade name of Anthem Insurance Companies, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CR-067576-24-CPN67268 Effective November 17, 2024 This article was updated on November 24, 2024 to change the effective date from October 26, 2024 to November 17, 2024. Effective on November 17, 2024, the following Carelon Medical Benefits Management, Inc. Clinical Appropriateness Guideline updates will be adopted for Anthem. This article is to communicate the plan adoption of these Carelon Medical Benefits Management, Inc. guidelines. Existing prior authorization requirements have not changed. In the event a prior authorization requirement or site of care review requirement for these services will be implemented, a separate notice will be distributed before the addition of any such prior authorization or site of care review requirement. You may access and download a copy of the current and upcoming guidelines here: - Musculoskeletal:
- Site of Care:
- Site of Care for Advanced Imaging
- Rehabilitative Site of Care
- Surgical Site of Care
The above guideline updates have a publish date of November 17, 2024. Please share this notice with other members of your practice and office staff. Anthem Blue Cross and Blue Shield is the trade name of Anthem Insurance Companies, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CR-065139-24-CPN64434, MULTI-ALL-CR-074348-24 Medical Policy & Clinical Guidelines | Hoosier Healthwise, Healthy Indiana Plan, Hoosier Care Connect, and IN PathWays for Aging | October 22, 2024 Medical Policies and Clinical Utilization Management Guidelines updateEffective December 7, 2024 The Medical Policies, Clinical Utilization Management (UM) Guidelines, and Third-Party Criteria below were developed and/or revised during Quarter Two, 2024. Note, several policies and guidelines were revised to provide clarification only and are not included. Some may have expanded rationales, medical necessity indications, or criteria, and some may involve changes to policy position statements that might result in services that previously were covered being found to be not medically necessary. Please share this notice with other providers in your practice and office staff. To view a guideline, visit Provider Medical Policies | Anthem.com. Medical PoliciesOn May 9, 2024, the Medical Policy and Technology Assessment Committee (MPTAC) approved the following Medical Policies applicable to Anthem. These medical policies take effect December 7, 2024. Publish Date | Medical Policy Number | Medical Policy Title | New or Revised | 6/28/2024 | ANC.00009 | Cosmetic and Reconstructive Services of the Trunk, Groin, and Extremities | Revised |
Anthem Blue Cross and Blue Shield is the trade name of Anthem Insurance Companies, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.
Providers who are contracted with Anthem Blue Cross and Blue Shield to serve Hoosier Healthwise, Healthy Indiana Plan, Hoosier Care Connect, and IN PathWays for Aging through an accountable care organization (ACO), participating medical group (PMG) or Independent Physician Association (IPA) are to follow guidelines and practices of the group. This includes but is not limited to authorization, covered benefits and services, and claims submittal. If you have questions, please contact your group administrator or your Anthem network representative. INBCBS-CD-068649-24-CPN68109 Effective February 1, 2025 Effective February 1, 2025, prior authorization (PA) requirements will change for the following code(s). The medical code(s) listed below will require PA by Anthem for Medicare Advantage members. Federal and state law, as well as state contract language and Centers for Medicare & Medicaid Services guidelines, including definitions and specific contract provisions/exclusions take precedence over these precertification rules and must be considered first when determining coverage. Non‑compliance with new requirements may result in denied claims. Prior authorization requirements will be added for the following code(s): Code | Code description | 0456U | Autoimmune (rheumatoid arthritis), next-generation sequencing (NGS), gene expression testing of 19 genes, whole blood, with analysis of anti-cyclic citrullinated peptides (CCP) levels, combined with sex, patient global assessment, and body mass index (BMI), algorithm reported as a score that predicts nonresponse to tumor necrosis factor inhibitor (TNFi) therapy PrismRA®, Scipher Medicine®, Scipher Medicine® | 0459U | β-amyloid (Abeta42) and total tau (tTau), electrochemiluminescent immunoassay (ECLIA), cerebral spinal fluid, ratio reported as positive or negative for amyloid pathology Elecsys® Total Tau CSF (tTau) and β-Amyloid (1-42) CSF II (Abeta 42) Ratio, Roche Diagnostics Operations, Inc (US owner/operator) | 0468U | Hepatology (nonalcoholic steatohepatitis [NASH]), miR-34a5p, alpha 2-macroglobulin, YKL40, HbA1c, serum and whole blood, algorithm reported as a single score for NASH activity and fibrosis NASHnext™ (NIS4™), Labcorp, Labcorp | J0687 | Injection, cefazolin sodium (WG Critical Care), not therapeutically equivalent to J0690, 500 mg | J0688 | Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg | J0689 | Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg | J0744 | Injection, ciprofloxacin for intravenous infusion, 200 mg | J2183 | Injection, meropenem (WG Critical Care), not therapeutically equivalent to J2185, 100 mg | J2184 | Injection, meropenem (B. Braun), not therapeutically equivalent to J2185, 100 mg | J2281 | Injection, moxifloxacin (Fresenius Kabi), not therapeutically equivalent to J2280, 100 mg |
Not all PA requirements are listed here. Detailed PA requirements are available to providers on anthem.com/medicareprovider on the Resources tab or for contracted providers by accessing Availity.com. Providers may also call Provider Services at the number on the back of the patient’s member ID card for assistance with PA requirements. UM AROW #: A2024M2186 Anthem Blue Cross and Blue Shield is the trade name of Anthem Insurance Companies, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CR-068215-24-CPN67511 As a reminder, and as previously communicated through letters we mailed to participating facilities on October 1, 2021, we allow reimbursement for only the primary or highest-valued procedure when multiple or bilateral procedures are performed on the same day or same session and at the same place of treatment when billed by a facility. A single surgical procedure is subject to multiple procedure reduction guidelines when submitted with multiple units. For specific Multiple Surgery — Facility reimbursement policy details, visit the reimbursement policy page. With your help, we can continually build towards a future of shared success. Anthem Blue Cross and Blue Shield is the trade name of Anthem Insurance Companies, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. INBCBS-CM-068271-24-CPN68051 Reimbursement Policies | Commercial | November 1, 2024 Change to Prior Authorization Requirements Reimbursement policy update: Nurse Practitioner and Physician Assistant ServicesBeginning with dates of service on or after February 1, 2025, Anthem will update the Nurse Practitioner and Physician Assistant Services — Professional reimbursement policy as indicated below. The following services will be removed from the policy and are eligible for a payment reduction when billed by a nurse practitioner (NP) or physician assistant (PA) provider: - Preventive Services
- Radiology Services
The following services will be added to the policy and will not be considered for a payment reduction when billed by a nurse practitioner (NP) or physician assistant (PA) provider: - Drugs
- Durable Medical Equipment, Prosthetics, Orthotics and Supplies
- Laboratory Services and Laboratory Screening Tests
For specific policy details, visit the reimbursement policy page by selecting here. Anthem Blue Cross and Blue Shield is the trade name of Anthem Insurance Companies, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-069779-24 Reimbursement Policies | Hoosier Healthwise, Healthy Indiana Plan, Hoosier Care Connect, and IN PathWays for Aging | November 1, 2024 Reimbursement policy update: Nurse Practitioner and Physician Assistant Services(Policy G-20002, effective 2/01/2025) Beginning with dates of service on or after 2/01/2025, Anthem will update the Nurse Practitioner and Physician Assistant Services reimbursement policy as indicated below. The following services were removed from the policy and are eligible for a payment reduction when billed by NP/PA provider. - Preventive Services
- Radiology Services
The following physician’s services are not subject to the NP/PA reimbursement payment reduction and the services are included in the not considered for payment reduction section. - Drugs
- Durable Medical Equipment Prosthetics, Orthotics, and Supplies (DMEPOS)
- Laboratory Services and Laboratory Screening Services
Under the current reimbursement structure, no payment reduction will be applied to the NP/PA services as mentioned above when the provider is employed by a physician group. For additional information, please review the Nurse Practitioner and Physician Assistant Services reimbursement policy at providers.anthem.com/in. Anthem Blue Cross and Blue Shield is the trade name of Anthem Insurance Companies, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.
Providers who are contracted with Anthem Blue Cross and Blue Shield to serve Hoosier Healthwise, Healthy Indiana Plan, Hoosier Care Connect, and IN PathWays for Aging through an accountable care organization (ACO), participating medical group (PMG) or Independent Physician Association (IPA) are to follow guidelines and practices of the group. This includes but is not limited to authorization, covered benefits and services, and claims submittal. If you have questions, please contact your group administrator or your Anthem network representative. INBCBS-CD-067374-24-CPN66373 At a glance: - High Performing Providers will also be known as Anthem Diamond Providers.
- Providers receiving a designation based on the Blue National Physician Performance Dataset will also be known as Anthem Diamond Providers (National).
High Performing Provider programOver the last several months, we have communicated with our providers about our High Performing Provider program. PCPs and specialists meeting certain criteria are designated High Performing Providers. High Performing Providers may also be referred to as Anthem Diamond Providers. As a reminder, the following specialties may be designated High Performing Providers (aka Anthem Diamond Providers) from this program: - PCP: family practice, general practice, geriatric medicine, internal medicine, pediatric medicine, and nurse practitioners
- Specialists: cardiology, endocrinology, nephrology, neurology, neurosurgery, obstetrics gynecology, orthopedic surgery, psychiatry, pulmonology, and rheumatology
If you have any questions about this program, contact Provider Services or your local provider relationship management representative. Blue National Physician Performance DatasetThis is an Anthem designation program for providers in networks supporting Anthem national accounts and certain out-of-area providers. As we previously communicated to you, effective January 1, 2025, Anthem may incorporate insights from the Blue National Physician Performance Dataset (Dataset) in various initiatives. For Anthem national accounts and certain out-of-area providers, Anthem will use data made available in the Dataset to assess individual physician’s performance at the NPI level. The individual physician’s performance is assessed across the three domains — cost of care/efficiency, quality of care, and appropriateness of care — for the following 16 primary care and specialty areas: cardiothoracic surgery, cardiovascular disease, endocrinology, neurology, ob/gyn, ophthalmology, orthopedics, pediatrics, primary care, pulmonology, surgery, urology, gastroenterology, otolaryngology, oncology, and radiation oncology. The providers who qualify for the designation from this Dataset program will also be referred to as Anthem Diamond Providers (National). If you have any questions regarding this, contact your local provider relationship management representative. Anthem Blue Cross and Blue Shield is the trade name of Anthem Insurance Companies, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-070326-24 Our digital-first initiative allows you to submit EDI-corrected claims using the Availity Essentials website or through electronic data interchange (EDI). The corrected claims process begins when a claim has already been adjudicated. Multiple types of errors that occur can typically be corrected quickly with the options below. Availity Essentials corrected claim submissionIf we have already accepted the original claim for processing, you can recreate it and submit it as a corrected replacement or cancellation (void) of the original claim. Follow these steps:- In the Availity Essentials menu, select Claims & Payments and then select Professional Claim or Facility Claim, depending on which type of claim you want to correct:
- Enter the claim information, and set the billing frequency and payer control number as follows:
- Replacement of Prior Claim or Void/Cancel of Prior Claim
- Billing Frequency (or Frequency Type) field in the Claim Information section (for professional and facility claims) or Ancillary Claim/Treatment Information section (for dental claims)
- Ensure all lines are submitted on the claim
- Note: The original claim processed will be voided, and the new corrected and/or replacement claim will be processed.
- Set the Payer Control Number (ICN / DCN) (or Payer Claim Control Number) field to the claim number we assigned to the claim. You can obtain this number from the 835 ERA or Remittance Inquiry on Payer Spaces.
- Submit the claim.
EDI corrected claim submissionCorrected claims submitted electronically must also have the applicable frequency code. The frequency code indicates the claim is a correction of a previously submitted and adjudicated claim. Providers should use one of the following: - For corrected professional (837P) claims, use one of the following frequency codes to indicate a correction was made to a previously submitted and adjudicated claim:
- 6 — Corrected Claim of Prior Claim
- 7 — Replacement of Prior Claim
- 8 — Void/Cancel Prior Claim
Note: When a replacement or corrected claim (0XX7 or 0XX6) is submitted, the original claim will be voided, and the new or corrected claim will be processed: - For corrected institutional (837I) claims, use bill type frequency codes to indicate a correction was made to a previously submitted and adjudicated claim:
- 0XX6 — Corrected Claim of Prior Claim
- 0XX7 — Replacement of Prior Claim
- 0XX8 — Void/Cancel Prior Claim
Please check with your practice management software vendor, billing service, or clearinghouse for the full details of submitting corrected claims. We encourage you and your staff to use the digital methods available to submit corrected claims to save costs in mailing, paper, and your valuable time. Anthem Blue Cross and Blue Shield is the trade name of Anthem Insurance Companies, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-068980-24 Pharmacy | Commercial | July 1, 2024 Change to Prior Authorization Requirements Correction: Specialty pharmacy updates — July 2024This article was updated on October 9, 2024, to remove Ilumya as non-preferred from the step therapy requirements section below. Ilumya is not being added to the step therapy program at this time. Specialty pharmacy updates for Anthem are listed below. Anthem’s medical specialty drug review team manages prior authorization (PA) clinical review of non-oncology use of specialty pharmacy drugs. Review of specialty pharmacy drugs for oncology use is managed by Carelon Medical Benefits Management, Inc., a separate company. Important to note: Currently, your patients may be receiving these medications without prior authorization. As of the effective date below, you may be required to request PA review for your patients’ continued use of these medications. Inclusion of National Drug Code (NDC) code on your claim will help expedite claim processing of drugs billed with a Not Otherwise Classified (NOC) code. Prior authorization updates Effective for dates of service on or after October 1, 2024, the following specialty pharmacy codes from current or new Clinical Criteria documents will be included in our PA review process. Access our Clinical Criteria to view the complete information for these prior authorization updates. Clinical Criteria | Drug | HCPCS or CPT® Code(s) | CC-0003* | Alyglo (immune globulin intravenous, human-stwk) | J1599 | CC-0062 | Simlandi (adalimumab-ryvk) | J3590 | CC-0261 | Winrevair (sotatercept-csrk) | C9399, J3590 |
* Oncology use is managed by Carelon Medical Benefits Management. Note: PA requests for certain medications may require additional documentation to determine medical necessity. Step therapy updates Effective for dates of service on or after October 1, 2024, the following specialty pharmacy codes from current or new Clinical Criteria documents will be included in our existing specialty pharmacy medical step therapy review process. Access our Clinical Criteria to view the complete information for these step therapy updates. Clinical Criteria | Status | Drug | HCPCS or CPT Code(s) | CC-0003 | Non-preferred | Alyglo (immune globulin intravenous, human-stwk) | J1599 | CC-0062 | Non-preferred | Cimzia (certolizumab pegol) | J0717 | CC-0042 | Non-preferred | Cosentyx intravenous (secukinumab) | C9399, J3490, J3590, C9166 | CC-0050 | Non-preferred | Omvoh (mirkizumab-mrkz) | C9168, J3590 |
Quantity limit updates Effective for dates of service on or after October 1, 2024, the following specialty pharmacy codes from current or new Clinical Criteria documents will be included in our quantity limit review process. Access our Clinical Criteria to view the complete information for these quantity limit updates. Clinical Criteria | Drug | HCPCS or CPT Code(s) | CC-0062 | Simlandi (adalimumab-ryvk) | J3590 | CC-0261 | Winrevair (sotatercept-csrk) | C9399, J3590 |
Carelon Medical Benefits Management, Inc. is an independent company providing utilization management services on behalf of the health plan. Anthem Blue Cross and Blue Shield is the trade name of Anthem Insurance Companies, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-060687-24-CPN60563, MULTI-BCBS-CM-069897-24 Pharmacy | Commercial | October 24, 2024 Change to Prior Authorization Requirements Specialty pharmacy updates — November 2024Specialty pharmacy updates for Anthem are listed below. Prior authorization clinical review of non-oncology use of specialty pharmacy drugs is managed by Anthem’s medical specialty drug review team. Review of specialty pharmacy drugs for oncology use is managed by Carelon Medical Benefits Management, Inc., a separate company. Note: Currently, your patients may be receiving these medications without prior authorization. As of the effective date below, you may be required to request prior authorization review for your patients’ continued use of these medications. Inclusion of the national drug code (NDC) on your claim will help expedite claim processing of drugs billed with a not otherwise classified (NOC) code. Prior authorization updatesEffective for dates of service on or after February 1, 2025, the following specialty pharmacy codes from current or new Clinical Criteria documents will be included in our prior authorization review process. Access our Clinical Criteria to view the complete information for these prior authorization updates. Clinical Criteria | Drug | HCPCS or CPT® code(s) | CC-0027* | Jubbonti; Wyost (denosumab-bbdz) | Q5136 | CC-0002* | Nypozi (filgrastim-txid) | C9399, J3590 | CC-0266* | Rytelo (imetelstat) | C9399, J9999 | CC-0003* | Yimmugo (immune globulin intravenous, human–dira) | J3590 |
* Oncology use is managed by Carelon Medical Benefits Management. Step therapy updatesEffective for dates of service on or after February 1, 2025, the following specialty pharmacy codes from current or new Clinical Criteria documents will be included in our existing specialty pharmacy medical step therapy review process. The current Orencia step therapy preferred product list under the medical benefit is being modified to include only those that are considered medical benefit drugs. Access our Clinical Criteria to view the complete information for these step therapy updates. Clinical Criteria | Status | Drug | HCPCS or CPT code(s) | CC-0002 | Non-preferred | Nypozi | C9399, J3590 | CC-0003 | Non-preferred | Yimmugo | J3590 |
Note: Prior authorization requests for certain medications may require additional documentation to determine medical necessity. Site of care updatesEffective for dates of service on and after February 1, 2025, the following specialty pharmacy codes from current or new clinical criteria documents will be included in our site of care review process. Access our Clinical Criteria to view the complete information for these site of care updates. Clinical Criteria | Drug | HCPCS or CPT code(s) | CC-0003 | Alyglo (immune globulin intravenous, human-stwk) | J1599 | CC-0066 | Tyenne (tocilizumab-aazg) | Q5135 |
Quantity limit updatesEffective for dates of service on or after February 1, 2025, the following specialty pharmacy codes from current or new Clinical Criteria documents will be included in our quantity limit review process. Access our Clinical Criteria to view the complete information for these quantity limit updates. Clinical Criteria | Drug | HCPCS or CPT code(s) | CC-0266 | Rytelo (imetelstat) | C9399, J9999 | CC-0027 | Jubbonti; Wyost (denosumab-bbdz) | Q5136 |
Carelon Medical Benefits Management, Inc. is an independent company providing utilization management services on behalf of the health plan. Anthem Blue Cross and Blue Shield is the trade name of Anthem Insurance Companies, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-069728-24-CPN69536 Enhanced adherence mitigates healthcare costs and improves patient outcomes and quality of life. Promoting medication adherence and advocating for statin use among diabetes patients is critical. Statin use in diabetes:- Diabetics are two to four times more likely to die from heart disease (American Heart Association).
- Statins lower LDL cholesterol, reducing cardiovascular events by 25 to 60%.
- Statin use is low, particularly in younger, female, and black individuals.
- Delayed statin use increases cardiovascular disease risk in diabetic patients.
- National guidelines recommend statin therapy for diabetics ages 40 to 75, regardless of LDL levels.
- CMS has adopted the Statin Use in Persons with Diabetes (SUPD) measure to combat cardiovascular death in diabetic patients.
Medication adherence:- Poor adherence increases morbidity and mortality, causing more than 125,000 deaths and 10% of hospitalizations annually in the United States.
- Forty-five percent of U.S. adults have hypertension and only 24% manage it effectively, largely due to non-adherence.
- High adherence in diabetic patients reduces hospitalization risks by 30%.
- Improved adherence can save $1,200 to $8,000 per patient annually.
Supporting patients:- Simplify the regimen: Prescribe medications with fewer daily doses.
- Regular follow-ups: Ensure correct medication use and adjust doses as needed.
- Clear communication: Explain medication benefits, risks of non-compliance, and side effects.
- Extended prescriptions: Provide 90 to 100 days’ supply and sufficient refills.
- Home delivery: Eliminate transportation barriers.
- Address statin hesitancy: Discuss pros and cons and involve family in decisions.
- Use technology: Set up reminders through mobile apps, SMS, email, or pill containers.
- Address cost issues: Prescribe affordable options and explore assistance programs.
- Personalized care: Tailor medication plans to the patient's lifestyle and needs.
References: - American Diabetes Association Professional Practice Committee. 10. Cardiovascular disease and risk management: Standards of Care in Diabetes—2024. Diabetes Care 2024;47(Suppl. 1):S179–S218
- Bradley CK, Wang TY, Li S, et al. Patient‐Reported Reasons for Declining or Discontinuing Statin Therapy: Insights From the PALM Registry. Journal of the American Heart Association. 2019;8(7). doi: https://doi.org/10.1161/jaha.118.011765
- Wall HK, Ritchey MD, Gillespie C, Omura JD, Jamal A, George MG. Vital Signs: Prevalence of Key Cardiovascular Disease Risk Factors for Million Hearts 2022 — United States, 2011–2016. MMWR Morb Mortal Wkly Rep 2018;67:983–991. doi: http://dx.doi.org/10.15585/mmwr.mm6735a4
- 2 Tarn DM, Barrientos M, Pletcher MJ, et al. Perceptions of Patients with Primary Nonadherence to Statin Medications. The Journal of the American Board of Family Medicine. 2021;34(1):123-131. doi: https://doi.org/10.3122/jabfm.2021.01.200262
- CDC. Statins and Diabetes: What You Should Know. Centers for Disease Control and Prevention. Published January 30, 2023. https://www.cdc.gov/diabetes/library/features/Statins_Diabetes.html
- Kearney PM, Blackwell L, Collins R, et al.; Cholesterol Treatment Trialists’ (CTT) Collaborators. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet 2008; 371:117–125
- Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. Circulation. 2019;140(11). doi: https://doi.org/10.1161/cir.0000000000000678
- Collins R, Reith C, Emberson J, et al. The Lancet. 2016;388(10059):2532-2561Interpretation of the evidence for the efficacy and safety of statin therapy. doi: https://doi.org/10.1016/S0140-6736(16)31357-5
- Hla D, Jones R, Blumenthal RS, et al. Assessing severity of statin side effects: Fact vs fiction. American College of Cardiology. April 09, 2018. Accessed May 17, 2023. https://www.acc.org/latest-in-cardiology/articles/2018/04/09/13/25/assessing-severity-of-statin-side-effects
- Reston JT, Buelt A, Donahue MP, Neubauer B, Vagichev E, McShea K. Interventions to Improve Statin Tolerance and Adherence in Patients at Risk for Cardiovascular Disease. Annals of Internal Medicine. 2020;173(10):806-812. doi: https://doi.org/10.7326/m20-4680
- Brown M, Sinsky CA. Medication Adherence. Improve Patient Outcomes and Reduce Costs. American Medical Association Steps Forward. 5 June 2015. https://edhub.ama-assn.org/steps-forward/module/2702595. Accessed 16 May 2023
- Eight reasons patients don’t take their medications. American Medication Association. Feb 22, 2023. Accessed May 17, 2023. https://www.ama-assn.org/delivering-care/patient-support-advocacy/8-reasons-patients-dont-take-their-medications
- El Halabi J, Minteer W, Boehmer KR. Identifying and Managing Treatment Nonadherence. Medical Clinics of North America. 2022;106(4):615-626. doi: https://doi.org/10.1016/j.mcna.2022.02.003
Anthem Blue Cross and Blue Shield is the trade name of Anthem Insurance Companies, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CR-069868-24-CPN69806 Optimizing HEDIS & STARS | Commercial / Medicare Advantage / Hoosier Healthwise, Healthy Indiana Plan, Hoosier Care Connect, and IN PathWays for Aging | November 1, 2024 Prevent flu and COVID-19: drive the change through vaccination- Encourage patients to get flu and COVID-19 vaccines for overall health safety.
- Use resources from LetsVaccinate.org, the CDC, and the American Lung Association to raise vaccination rates.
- Research validates that vaccinations prevent severe COVID-19 outcomes and significantly lower the risk of intensive care unit (ICU) admission and death from flu.
You care about your patients and want to keep them healthy. That’s why it’s important that you and your care team remind your patients to stay up to date with their flu and COVID-19 vaccines. Physician recommendation is the greatest motivator for people to vaccinate themselves and their family members. Customized patient outreach can influence your patients’ decisions to get recommended vaccines. The tools below were developed by clinical experts to support you and your care team in educating your patients on the health benefits of vaccines: - Let's Vaccinate provides ready-to-use resources and strategies to help your care team increase vaccination rates.
- CDC’s vaccine information for healthcare professionals offers evidence-based immunization strategies and best practices critical to implementing a successful vaccination program.
- Fend Off Flu is the American Lung Association’s campaign to increase flu knowledge and vaccination rates.
Research shows: - In a 2021 study among adults hospitalized with flu, vaccinated patients had a 26% lower risk of ICU admission and a 31% lower risk of death from flu compared with those who were unvaccinated.*
- COVID-19 vaccinations remain the safest strategy for avoiding hospitalizations, long-term health outcomes, and death from COVID-19.*
We’re committed to active involvement with our care provider partners and going beyond the contract to create a real impact on the health of our communities. * https://www.cdc.gov/covid/vaccines/benefits.html?CDC_AAref_Val=https://www.cdc.gov/coronavirus/2019-ncov/vaccines/vaccine-benefits.html Anthem Blue Cross and Blue Shield is the trade name of Anthem Insurance Companies, Inc., independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.
Providers who are contracted with Anthem Blue Cross and Blue Shield to serve Hoosier Healthwise, Healthy Indiana Plan, Hoosier Care Connect, and IN PathWays for Aging through an accountable care organization (ACO), participating medical group (PMG) or Independent Physician Association (IPA) are to follow guidelines and practices of the group. This includes but is not limited to authorization, covered benefits and services, and claims submittal. If you have questions, please contact your group administrator or your Anthem network representative. INBCBS-CDCRCM-065048-24-CPN64664 |